We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis Wins Advisory Panel Support for Approval of Tobi Alternative
Novartis Wins Advisory Panel Support for Approval of Tobi Alternative
September 7, 2012
The FDA’s Anti-Infective Drugs Advisory Committee has recommended the FDA approve Novartis’ inhaler-based version of cystic fibrosis (CF) drug Tobi.